News Trends, News Analysis, News Archive.



Hot Topics Related To `mid-stage trial`

In Internet Explorer versions up to 8, things inside the canvas are inaccessible!

News Timeline

100 Articles About mid-stage trial

healthNews reuters.com

Roche lymphoma drug drives high remission rate, longer survival: study

(Reuters) - An experimental Roche Holding AG drug, added to standard therapy, led to a far higher rate of remission and helped patients with an advanced, aggressive blood cancer live significantly longer than the standard treatment alone, according to data from a mid-stage trial released at a medical meeting on Sunday.

companyNews reuters.com

Roche lymphoma drug drives high remission rate, longer survival-study

Dec 10 (Reuters) - An experimental Roche Holding AG drug, added to standard therapy, led to a far higher rate of remission and helped patients with an advanced, aggressive blood cancer live significantly longer than the standard treatment alone, according to data from a mid-stage trial released at a medical meeting on Sunday.

healthNews reuters.com

Sage shares surge as depression drug succeeds in mid-stage trial

(Reuters) - Drug developer Sage Therapeutics Inc's shares soared as much as 85 percent to a record high on Thursday after its experimental drug to reduce the symptoms of depression succeeded in a mid-stage trial.

companyNews reuters.com

UPDATE 3-Sage shares surge as depression drug succeeds in mid-stage trial

* Shares surge as much as 85 pct (Adds details on drug's mechanism, analyst comment, updates shares)

healthNews reuters.com

Sage shares surge as depression drug succeeds mid-stage trial

(Reuters) - Sage Therapeutics Inc's shares surged more than 63 percent premarket on Thursday, on track to add about $2.5 billion to the company's market value, after its drug succeeded in reducing the symptoms of depression in a mid-stage trial.

healthNews reuters.com

Galectin slumps after NASH drug misses main goal of mid-stage trial

(Reuters) - Galectin Therapeutics Inc said its drug for the complex progressive fatty liver disease NASH led to some clinically meaningful results in patients with cirrhosis, but failed to achieve the main goal of a mid-stage trial, sending its shares plunging 48 percent on Tuesday.

healthNews reuters.com

Therapix expects to have results of Tourette's drug trial by end of first quarter

TEL AVIV (Reuters) - Israel's Therapix Biosciences said on Monday it expects by the end of March to have the results from its mid-stage trial of a cannabinoid-based drug for treating Tourette's syndrome which could be worth billions of dollars in revenues.

companyNews reuters.com

Therapix expects to have results of Tourette's drug trial by end of Q1

TEL AVIV, Dec 4 (Reuters) - Israel's Therapix Biosciences said on Monday it expects by the end of March to have the results from its mid-stage trial of a cannabinoid-based drug for treating Tourette's syndrome which could be worth billions of dollars in revenues.

companyNews reuters.com

CORRECTED-Lilly/Incyte pill beats placebo in mid-stage eczema trial

Sept 14 (Reuters) - Eli Lilly and Co and Incyte Corp on Thursday said a mid-stage trial of their oral drug baricitinib showed that at the highest dose it worked better than placebo for people with moderate-to-severe atopic dermatitis.

healthNews reuters.com

Lilly/Incyte pill beats placebo in mid-stage eczema trial

(Reuters) - Eli Lilly and Co and Incyte Corp on Thursday said a mid-stage trial of their oral drug baricitinib showed that at the highest dose it worked better than placebo for people with moderate-to-severe atopic dermatitis.

companyNews reuters.com

UPDATE 1-Johnson & Johnson's flu drug succeeds in mid-stage trial

June 14 (Reuters) - Johnson & Johnson said on Wednesday its experimental flu drug significantly reduced viral load in patients with a type of influenza in a mid-stage study.

healthNews reuters.com

Johnson & Johnson's flu drug succeeds in mid-stage trial

(Reuters) - Johnson & Johnson said on Wednesday its experimental flu drug significantly reduced viral load compared to a placebo in a mid-stage study of patients with a type of influenza.

companyNews reuters.com

Swiss biotech NLS Pharma's ADHD drug succeeds in mid-stage study

May 31 (Reuters) - Swiss biotech NLS Pharma AG said on Wednesday mid-stage trial data showed that its drug to treat attention deficit hyperactivity disorder (ADHD) greatly reduced symptoms in adults, paving the way for a late-stage trial.

healthNews reuters.com

ImmunoGen drug moving ahead in single-agent, combination trials

(Reuters) - Latest results from a mid-stage trial of ImmunoGen Inc's experimental antibody-drug conjugate show that it shrinks or stabilizes tumors in nearly half of advanced ovarian cancer patients with at least medium levels of a key biomarker whose disease has become resistant to standard chemotherapy.

companyNews reuters.com

FDA places clinical hold on Concert Pharma's hair loss drug

May 17 (Reuters) - Concert Pharmaceuticals Inc said on Wednesday the U.S. Food and Drug Administration imposed a clinical hold on a mid-stage trial testing the company's drug to treat alopecia areata, a type of hair loss.

companyNews reuters.com

Bristol-Myers NASH drug reduces liver fat in midstage study

April 22 (Reuters) - Bristol-Myers Squibb Co said its lead experimental drug for nonalcoholic steatohepatitis, or NASH, significantly reduced liver fat versus placebo, according to data from a mid-stage trial presented at a medical meeting on Saturday.

healthNews reuters.com

Allergan to move Botox into late-stage testing for depression

(Reuters) - Allergan plc said on Wednesday that its Botox blockbuster wrinkle treatment just missed achieving a significant improvement in treating depression in a mid-stage trial, but it found the data encouraging enough to move into larger Phase III testing.

healthNews reuters.com

NIAID begins vaccinations in a mid-stage trial for Zika

(Reuters) - The U.S. National Institute of Allergy and Infectious Diseases (NIAID) said on Friday that vaccinations have begun in a mid-stage trial testing an experimental DNA vaccine for Zika.

hotStocksNews reuters.com

UPDATE 1-Halozyme's pancreatic cancer drug succeeds in mid-stage trial

Jan 5 (Reuters) - Halozyme Therapeutics Inc said its flagship drug delivery technology in tandem with therapies from Celgene Corp and Eli Lilly and Co succeeded in a mid-stage study involving...

healthNews reuters.com

Halozyme's pancreatic cancer drug succeeds in mid-stage trial

(Reuters) - Halozyme Therapeutics Inc said its lead drug to treat a late form of pancreated cancer met the main goal in a mid-stage study, sending its shares soaring in premarket trading.

companyNews reuters.com

Synthetic Biologics' C. difficile mid-stage study meets main goal

Jan 5 (Reuters) - Synthetic Biologics Inc said on Thursday its experimental product designed to reduce antibiotic-resistant infections outperformed a placebo in a mid-stage trial.

governmentFilingsNews reuters.com

BRIEF-Protalix Biotherapeutics says last patient enrolled in mid-stage trial

* Protalix Biotherapeutics - expects to report interim top-line results from study during first week of Jan 2017, and full results before end of Q1 of 2017

healthNews reuters.com

Novartis says 82 percent of leukemia patients in remission after CAR-T

(Reuters) - An experimental cancer therapy being developed by Novartis AG eliminated an aggressive form of blood cancer in 82 percent of children and young adults treated with modified immune cells in a mid-stage trial, the company said on Saturday.

companyNews reuters.com

Novartis says 82 pct of leukemia patients in remission after CAR-T

Dec 3 (Reuters) - An experimental cancer therapy being developed by Novartis AG eliminated an aggressive form of blood cancer in 82 percent of children and young adults treated with modified immune cells in a mid-stage trial, the company said on Saturday.

governmentFilingsNews reuters.com

BRIEF-Global Blood Therapeutics to initiate mid-stage trial for the treatment of idiopathic pulmonary fibrosis

* Global Blood Therapeutics announces initiation of phase 2a trial of GBT440 in idiopathic pulmonary fibrosis (IPF)

governmentFilingsNews reuters.com

BRIEF-Summit enrols patients in the U.S. into a mid-stage trial of Ezutromid in patients with DMD

* Summit enrols patients in the United States into PhaseOut DMD, a phase 2 clinical trial of Ezutromid in patients with DMD Source text for Eikon: Further company coverage:

companyNews reuters.com

BRIEF-Caladrius biosciences begins second cohort of mid-stage trial for treating diabetes

* Caladrius Biosciences has modified T-rex study protocol to allow for an earlier than planned resumption of enrollment for remaining patients based on DSMB recommendation

rbssHealthcareNews reuters.com

UPDATE 2-Regeneron's Eylea combination therapy fails mid-stage study

Sept 30 (Reuters) - Regeneron Pharmaceuticals Inc said a combination therapy containing its flagship eye drug, Eylea, was inferior to Eylea alone in a mid-stage trial involving patients with wet age-related macular degeneration (AMD), a leading cause of blindness in the elderly.

governmentFilingsNews reuters.com

UPDATE 1-Regeneron's Eylea combination therapy fails mid-stage study

Sept 30 (Reuters) - Regeneron Pharmaceuticals Inc said a combination therapy containing its flagship eye drug, Eylea, was inferior to Eylea alone in a mid-stage trial involving patients with wet...

healthNews reuters.com

Regeneron's Eylea combination therapy fails mid-stage study

(Reuters) - Regeneron Pharmaceuticals Inc said a combination therapy containing its flagship eye drug, Eylea, was inferior to Eylea alone in a mid-stage trial involving patients with wet age-related macular degeneration (AMD), a leading cause of blindness.

healthNews reuters.com

Mesoblast cell treatment shows promise in rheumatoid arthritis : study

(Reuters) - Mesoblast Ltd on Monday said its experimental stem-cell treatment led to significant improvements of symptoms and disease activity in patients whose rheumatoid arthritis had stopped being helped by widely used biotech medicines, according to data from a mid-stage trial.

companyNews reuters.com

Mesoblast cell treatment shows promise in rheumatoid arthritis -study

Aug 8 (Reuters) - Mesoblast Ltd on Monday said its experimental stem-cell treatment led to significant improvements of symptoms and disease activity in patients whose rheumatoid arthritis had stopped being helped by widely used biotech medicines, according to data from a mid-stage trial.

companyNews reuters.com

Novo's insulin pill shows promise in mid-stage trial

Aug 5 (Reuters) - Novo Nordisk is making progress in the hunt for an oral form of insulin that can be given as a pill rather than an injection, marking a sliver of good news amid disappointing second-quarter results.

rbssHealthcareNews reuters.com

BRIEF-VM Biopharma obtained INDA from Korean healh regulator for mid-stage trial of gene therapy drug

* Obtained inda from ministry of food and drug safety in korea for phase ii clinical trial of investigational gene therapy drug, vm202 Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

companyNews reuters.com

BRIEF-Shire reports results for mid-stage trial of shp607 in extremely premature infants

* Shire announces top-line results for phase 2 trial of shp607 in extremely premature infants Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

rbssHealthcareNews reuters.com

BRIEF-Spring Bank Pharma doses first patients in mid-stage trial testing HBV patients without cirrhosis

* Spring bank pharmaceuticals says begun dosing first patients in global phase 2 clinical program evaluating sb 9200 in hbv patients without cirrhosis

hotStocksNews reuters.com

UPDATE 1-StemCells terminates mid-stage study; to wind down ops

May 31 (Reuters) - StemCells Inc said on Tuesday it had terminated a mid-stage trial testing its therapy in spinal cord injury and that its board had decided to wind down the company.

healthNews reuters.com

StemCells terminates mid-stage study; to wind down operations

(Reuters) - StemCells Inc said on Tuesday it had terminated a mid-stage trial in spinal cord injury and that its board had decided to wind down the company.

governmentFilingsNews reuters.com

BRIEF-Synthetic Biologics releases data from two mid-stage trials on drug for irritable bowel syndrome with constipation

May 23 (Reuters) - Synthetic Biologics Announces Detailed Data From Two Syn

healthNews reuters.com

German Merck, Pfizer immunotherapy shows promise in rare skin cancer

(Reuters) - Germany's Merck KGaA on Wednesday reported encouraging interim data against a rare and aggressive form of skin cancer from a mid-stage trial of its experimental drug that helps the immune system attack tumors.

rbssHealthcareNews reuters.com

UPDATE 1-Vitae Pharma's psoriasis drug succeeds in mid-stage study

March 16 (Reuters) - Drug developer Vitae Pharmaceuticals Inc said its experimental psoriasis drug significantly reduced the skin condition in patients from a mid-stage trial, sending its shares up 70 percent in after-hours trading.

companyNews reuters.com

Vitae Pharma's psoriasis drug succeeds in mid-stage study

March 16 (Reuters) - Drug developer Vitae Pharmaceuticals Inc said its experimental psoriasis drug significantly reduced the skin condition in patients from a mid-stage trial.

healthNews reuters.com

Aldeyra's eye drug effective in mid-stage trial; shares soar

(Reuters) - Aldeyra Therapeutics Inc said its eye drug was more effective than a placebo in treating itching and tearing associated with allergic conjunctivitis in a mid-stage study.

marketsNews reuters.com

UPDATE 2-Aldeyra's eye drug effective in mid-stage trial; shares soar

* Shares jump 56 pct; record intraday percentage gain (Adds shares, analyst comments)

healthNews reuters.com

Zafgen obesity drug succeeds in mid-stage trial, shares rise

(Reuters) - Zafgen Inc's controversial obesity drug reduced the weight of overweight diabetic patients, the second trial success in as many months for the drug on which all tests have been halted since December after two patients died.

hotStocksNews reuters.com

UPDATE 1-Zafgen's obesity drug succeeds in mid-stage trial

Feb 18 (Reuters) - Drug developer Zafgen Inc said on Thursday that its drug to treat obesity in diabetic patients met the main goal of reducing body weight.

businessNews reuters.com

Zafgen's obesity drug succeeds in mid-stage trial

(Reuters) - Drug developer Zafgen Inc said on Thursday that its drug to treat obesity in diabetic patients met the main goal of reducing body weight.

companyNews reuters.com

UPDATE 1-Recro Pharma's lead painkiller succeeds in mid-stage trial

Jan 6 (Reuters) - Recro Pharma Inc said its lead painkiller reduced pain in post-operative orthopedic surgery patients and was safe and well tolerated, in a mid-stage trial.

companyNews reuters.com

Recro Pharma's lead painkiller succeeds in mid-stage trial

Jan 6 (Reuters) - Drugmaker Recro Pharma Inc said its lead painkiller was safe and well tolerated in post-operative orthopedic surgery patients in a mid-stage trial.

healthNews reuters.com

Conatus liver drug shows promise in mid-stage trial

(Reuters) - Conatus Pharmaceuticals Inc said its experimental drug reduced the presence of a protein fragment in patients with liver cirrhosis in a mid-stage trial.

companyNews reuters.com

UPDATE 1-Conatus liver drug shows promise in mid-stage trial

Jan 5 (Reuters) - Conatus Pharmaceuticals Inc said its experimental drug reduced the presence of a protein fragment in patients with liver cirrhosis in a mid-stage trial.

companyNews reuters.com

Conatus liver drug shows positive results in mid-stage trial

Jan 5 (Reuters) - Conatus Pharmaceuticals Inc said its experimental drug, emricasan, succeeded in reducing the presence of a protein fragment in patients with liver cirrhosis in a mid-stage trial.

companyNews reuters.com

Raptor to advance neurodegenerative disorder drug in registration study

Dec 10 (Reuters) - Raptor Pharmaceutical Corp reported promising data from a mid-stage trial of its experimental neurodegenerative disorder drug, codenamed RP103, and said it would advance it in a registration study.

companyNews reuters.com

AstraZeneca lupus drug impresses in mid-stage trial

LONDON, Nov 10 (Reuters) - AstraZeneca's experimental lupus drug anifrolumab significantly cut disease activity in a mid-stage clinical trial, boosting hopes for a medicine the company believes could become a $1 billion-a-year seller.

companyNews reuters.com

UPDATE 1-FDA puts clinical hold on Advaxis cancer drug

Oct 6 (Reuters) - Advaxis Inc said the U.S. Food and Drug Administration has put on hold the mid-stage trials of its experimental cancer drug after a patient died, sending its shares down 27 percent in extended trading.

healthNews reuters.com

Heron Therapeutics' pain drug meets mid-stage trial goal

(Reuters) - Drug developer Heron Therapeutics Inc said its experimental pain drug met the main goal of a mid-stage study, pushing its shares up about 33 percent in after-market trading.

rbssHealthcareNews reuters.com

UPDATE 1-Cannabis drug shows promise in treating schizophrenia

Sept 15 (Reuters) - An experimental cannabis drug for treating schizophrenia, developed by UK-based GW Pharmaceuticals Plc , was found to be superior to a placebo in a mid-stage trial.

healthNews reuters.com

GW Pharma cannabis drug succeeds in schizophrenia study

(Reuters) - UK-based GW Pharmaceuticals Plc said its experimental cannabis drug for treating schizophrenia was found to be superior to a placebo in a mid-stage trial.

rbssHealthcareNews reuters.com

BRIEF-GW Pharma reports positive results for schizophrenia drug in mid-stage trial

* Positive top line results from exploratory phase 2a placebo-controlled clinical trial of Cannabidiol (CBD) in 88 patients

companyNews reuters.com

XenoPort's psoriasis drug effective in mid-stage study

Sept 15 (Reuters) - Drug developer XenoPort Inc said its experimental drug was effective in treating psoriasis, a type of chronic inflammatory disease of the skin, in a mid-stage trial.

marketsNews reuters.com

UPDATE 2-AbbVie to seek approval for potential blockbuster leukemia drug

Aug 12 (Reuters) - AbbVie Inc on Wednesday said its experimental treatment for a form of leukemia associated with a gene mutation met its main goal in a mid-stage trial and that the company would...

healthNews reuters.com

AbbVie to seek approval for potential blockbuster leukemia drug

(Reuters) - AbbVie Inc on Wednesday said its experimental treatment for a form of leukemia associated with a gene mutation met its primary goal in a mid-stage trial and that the company would seek U.S. approval of the medicine, which analysts have said has blockbuster sales potential.

companyNews reuters.com

UPDATE 1-AbbVie to seek approval for potential blockbuster leukemia drug

Aug 12 (Reuters) - AbbVie Inc on Wednesday said its experimental treatment for a form of leukemia associated with a gene mutation met its primary goal in a mid-stage trial and that the company would seek U.S. approval of the medicine, which analysts have said has blockbuster sales potential.

companyNews reuters.com

AbbVie to seek FDA approval for leukemia drug after trial success

Aug 12 (Reuters) - AbbVie Inc on Wednesday said its experimental treatment for a form of leukemia associated with a gene mutation met its primary goal in a mid-stage trial and that the company would seek U.S. approval of the medicine, which analysts have said has blockbuster sales potential.

healthNews reuters.com

Celladon to suspend development of gene-therapy drug

(Reuters) - Celladon Corp said it would suspend further development of its gene-therapy drug for heart failure, months after the treatment failed a mid-stage trial.

healthNews reuters.com

Alcobra's only drug fails mid-stage trial for genetic disorder

(Reuters) - The only drug in Alcobra Ltd's pipeline failed a mid-stage trial testing it against a type of genetic disorder that can cause autism and ADHD, sending the company's shares down as much as 19 percent on Wednesday.

hotStocksNews reuters.com

UPDATE 1-Alcobra's genetic disorder drug fails mid-stage trial

June 24 (Reuters) - Israel-based Alcobra Ltd said its drug failed in a mid-stage trial to treat a type of genetic disorder that could cause autism and attention deficit hyperactivity disorder.

companyNews reuters.com

Alcobra's genetic disorder drug fails in mid-stage trial

June 24 (Reuters) - Israel-based Alcobra Ltd said its experimental drug failed in a mid-stage trial to treat Fragile X Syndrome, a type of genetic disorder that could cause autism.

healthNews reuters.com

Avalanche eye therapy meets safety goal; vision improvement modest

(Reuters) - Avalanche Biotechnologies Inc's experimental gene therapy for a leading cause of blindness met its primary safety goal in a small mid-stage trial, while staving off vision loss.

companyNews reuters.com

UPDATE 1-Avalanche eye therapy meets safety goal; vision improvement modest

June 15 (Reuters) - Avalanche Biotechnologies Inc's experimental gene therapy for a leading cause of blindness met its primary safety goal in a small mid-stage trial, while staving off vision loss.

companyNews reuters.com

Avalanche eye gene therapy meets safety goal

June 15 (Reuters) - Avalanche Biotechnologies Inc's experimental gene therapy for a leading cause of blindness met its primary safety goal in a small mid-stage trial, while staving off vision loss.

healthNews reuters.com

FDA approves mid-stage trial of vaccine to reverse type 1 diabetes

(Reuters Health) - Diabetes researchers are hoping that an almost century-old vaccine for preventing tuberculosis may also reverse type 1 diabetes.

healthNews reuters.com

GlobeImmune, Gilead Hepatitis B drug fails in mid-stage study

(Reuters) - GlobeImmune Inc said its experimental hepatitis B drug did not meet the main goal of reducing infection in patients after 24 weeks, in a mid-stage trial.

companyNews reuters.com

UPDATE 1-GlobeImmune, Gilead Hep B drug fails in mid-stage study

May 27 (Reuters) - GlobeImmune Inc said its experimental hepatitis B drug did not meet the main goal of reducing infection in patients after 24 weeks, in a mid-stage trial.

companyNews reuters.com

GlobeImmune, Gilead Hep B drug fails in mid-stage study

May 27 (Reuters) - GlobeImmune Inc said its experimental hepatitis B drug did not meet the main goal of reducing infection in patients after 24 weeks, in a mid-stage trial.

healthNews reuters.com

Otonomy's ear drug fails mid-stage trial, shares slide

(Reuters) - Otonomy Inc said its experimental drug did not meet the main goal of reducing the incidence of vertigo in a mid-stage trial in patients suffering from Ménière's disease.

companyNews reuters.com

UPDATE 1-Otonomy's ear drug fails mid-stage trial, shares slide

May 21 (Reuters) - Otonomy Inc said its experimental drug did not meet the main goal of reducing the incidence of vertigo in a mid-stage trial in patients suffering from Ménière's disease.

companyNews reuters.com

Otonomy Inc's ear drug fails mid-stage trial

May 21 (Reuters) - Drug developer Otonomy Inc said its experimental drug did not meet the main goal of reducing the incidence of vertigo in a mid-stage trial in patients suffering from Ménière's disease.

companyNews reuters.com

Roche immunotherapy improves lung cancer survival

May 13 (Reuters) - A mid-stage trial of Roche Holding AG's experimental immunotherapy showed that it doubled the likelihood of survival for lung cancer patients with the highest levels of a specific biomarker.

hotStocksNews reuters.com

Genfit shares drop as much as 42 pct after liver disease drug fails trial

PARIS, March 27 (Reuters) - Shares in French drugmaker Genfit opened down 42 percent on Friday after its liver disease drug failed a mid-stage trial.

healthNews reuters.com

Lpath's kidney cancer drug fails mid-stage trial

(Reuters) - Drug developer Lpath Inc said its experimental drug to treat renal cell carcinoma, the most common form of kidney cancer, failed to meet its main goal in a mid-stage trial.

hotStocksNews reuters.com

UPDATE 1-Lpath's kidney cancer drug fails mid-stage trial

March 24 (Reuters) - Drug developer Lpath Inc said its experimental drug to treat renal cell carcinoma, the most common form of kidney cancer, failed to meet its main goal in a mid-stage trial.

companyNews reuters.com

FDA seeks more safety data on Antares testosterone drug

Jan 13 (Reuters) - Antares Pharma Inc said the U.S. Food and Drug Administration has asked for additional safety data on its testosterone drug after a patient developed hives in a mid-stage trial.

companyNews reuters.com

FDA asks Arrowhead to cut Hep B drug dosage in mid-stage trial

Jan 12 (Reuters) - Drug developer Arrowhead Research Corp said the U.S. Food and Drug Administration asked the company to reduce the dosage of its experimental Hepatitis B treatment and requested additional data from the drug's mid-stage trial.

companyNews reuters.com

UPDATE 1-Alkermes schizophrenia drug meets main goal in mid-stage trial

(Adds details, stock movement) (Adds details, share move)

companyNews reuters.com

Alkermes schizophrenia drug meets main goal in mid-stage trial

Jan 7 (Reuters) - Alkermes Plc said its experimental drug to treat schizophrenia met the main goal in a mid-stage trial.

companyNews reuters.com

Swiss biotech Genkyotex eyes IPO in second half of 2015

ZURICH, Jan 7 (Reuters) - Swiss biotech company Genkyotex is weighing up a possible initial public offering (IPO) in the second half of this year if results of a mid-stage trial for its experimental drug to treat kidney damage caused by diabetes prove promising.

healthNews reuters.com

Cytrx cancer drug shows promise in trial, shares rise

(Reuters) - Cytrx Corp said interim data showed its experimental cancer drug was effective in a mid-stage trial on patients with a deadly form of brain cancer, sending its shares up 33 percent before the bell.

hotStocksNews reuters.com

UPDATE 1-Cytrx cancer drug shows promise in trial, shares rise

Jan 6 (Reuters) - Cytrx Corp said interim data showed its experimental cancer drug was effective in a mid-stage trial on patients with a deadly form of brain cancer, sending its shares up 33 percent...

rbssHealthcareNews reuters.com

BRIEF-Vectura's asthma drug meets main goal in mid-stage trial

* Investigational drug/device combination VR475 met primary endpoint and has shown significant clinical benefit in a phase IIb/III trial in severe asthma patients

companyNews reuters.com

UPDATE 1-FDA lifts clinical hold on Flexion's lead drug

Dec 1 (Reuters) - The U.S. Food and Drug Administration lifted a clinical hold on Flexion Therapeutics Inc's lead experimental drug to relieve osteoarthritis-related pain, allowing the company to resume its mid-stage trial.

companyNews reuters.com

FDA lifts hold on Flexion's lead drug

Dec 1 (Reuters) - The U.S. Food and Drug Administration lifted a clinical hold on Flexion Therapeutics Inc's lead experimental drug to relieve osteoarthritis-related pain, allowing the company to resume mid-stage trials.

healthNews reuters.com

Synergy Pharma constipation drug succeeds mid-stage trial

(Reuters) - Synergy Pharmaceuticals Inc said its experimental drug for opioid-induced constipation was found safe and effective in a mid-stage trial.

hotStocksNews reuters.com

UPDATE 1-Synergy Pharma constipation drug succeeds mid-stage trial

Nov 19 (Reuters) - Synergy Pharmaceuticals Inc said its experimental drug for opioid-induced constipation was found safe and effective in a mid-stage trial.

hotStocksNews reuters.com

REFILE-Synergy Pharma constipation drug succeeds mid-stage trial

Nov 19 (Reuters) - Synergy Pharmaceuticals Inc said its experimental drug for opioid induced constipation was found safe and effective in a mid-stage trial.

healthNews reuters.com

Receptos bowel disorder drug meets mid-stage trial goal

(Reuters) - Receptos Inc said its experimental ulcerative colitis drug met the main goal in a mid-stage trial, sending its shares up 30 percent.

hotStocksNews reuters.com

UPDATE 1-Receptos bowel disorder drug meets mid-stage trial goal

Oct 27 (Reuters) - Receptos Inc said its experimental ulcerative colitis drug met the main goal in a mid-stage trial, sending its shares up 30 percent.

hotStocksNews reuters.com

UPDATE 1-Akebia's lead drug succeeds in mid-stage trial

Oct 27 (Reuters) - Akebia Therapeutics Inc said its lead experimental drug was successful in raising and maintaining hemoglobin levels in certain patients with anemia related to chronic kidney...

healthNews reuters.com

Akebia's lead drug succeeds in mid-stage trial

(Reuters) - Akebia Therapeutics Inc said its lead experimental drug was successful in raising and maintaining hemoglobin levels in certain patients with anemia related to chronic kidney disease.

healthNews reuters.com

Oramed's oral insulin succeeds in study, shares jump

(Reuters) - Oramed Pharmaceuticals Inc said its oral insulin capsule appeared to be safe and was well-tolerated by diabetics in a mid-stage trial.